CRISPR genome editing advances against gastric cancer
Exploration of Digestive Diseases · 2025
DOI: 10.37349/edd.2025.1005106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration of Digestive Diseases, 2025. Verfasst von Mengmeng Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastric cancer (GC) is one of the most common malignant tumors, ranking fifth in incidence and third in mortality worldwide. China also bears a high burden of GC, second only to lung cancer. With the advancement of clustered regularly interspaced short palindromic repeats (CRISPR) technology, the mechanisms underlying the development and progression of various tumor types have been elucidated. This article summarizes the application of CRISPR technology in the functional genomics identification and target screening of GC genes, explores the use of chimeric antigen receptor T (CAR-T) cell therapy for solid gastric tumors, and discusses the progress and significance of CRISPR technology in constructing GC models using organoids.
Zitieren
APA
Zhang, M., Su, Q., Zhang, Q., & Yang, X. (2025). CRISPR genome editing advances against gastric cancer. Exploration of Digestive Diseases. https://doi.org/10.37349/edd.2025.1005106
Vancouver
Zhang M, Su Q, Zhang Q, Yang X. CRISPR genome editing advances against gastric cancer. Exploration of Digestive Diseases. 2025. doi:10.37349/edd.2025.1005106
BibTeX
@article{Zhang2025,
author = {Zhang, Mengmeng and Su, Qihang and Zhang, Qian and Yang, Xianguang},
title = {CRISPR genome editing advances against gastric cancer},
journal = {Exploration of Digestive Diseases},
year = {2025},
doi = {10.37349/edd.2025.1005106}
}
EUVIMED